Literature DB >> 75929

Leukocyte complement: neoantigens of the membrane attack complex on the surface of human leukocytes prepared from defibrinated blood.

J S Sundsmo, W P Kolb, H J Müller-Eberhard.   

Abstract

The neoantigenic determinants (neoAg) which have been identified in the human C5b-9 membranolytic C complex were detected here by the direct fluorescent antibody technique on the surface of 27 +/- 11% of viable peripheral blood leukocytes (PBL). The cells were prepared from defibrinated blood by sedimentation on Ficoll-Hypaque. Specificity of the antisera was established by quantitative inhibition of the fluorescent staining reaction, and of agglutination of EAC1-7, by highly purified C5b-9 complex. No inhibition was observed with fresh normal human serum. The majority of the PBL with surface neoAg was found in the B lymphocyte subpopulation that failed to form rosettes with sheep erythrocytes. NeoAg on B lymphocytes was removed to differing degrees by trypsin, papain, or pepsin treatment, and by maintaining the cells at 4 degree C for 20 hr in serum-free medium. The individual components, C5, C6, C7, C8, and C9, were also detected on the surface of PBL. With differential fluorescent stains, C5 and neoAg as well as C8 and neoAg could be detected on the same cells. The results indicate that viable B lymphocytes prepared from defibrinated blood, have the components of the membrane attack complex of C on their surface. The concomitant occurrence of the neoAg indicates that these proteins are present at least in part in the form of the assembled terminal complex.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 75929

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  In vitro complement activation by rabbit lymphocytes and thymocytes in autologous serum.

Authors:  A B Wilson; P J Lachmann; R R Coombs
Journal:  Immunology       Date:  1979-05       Impact factor: 7.397

2.  Proteolytic transformation of SC5b-9 into an amphiphilic macromolecule resembling the C5b-9 membrane attack complex of complement.

Authors:  S Bhakdi; B Bhakdi-Lehnen; J Tranum-Jensen
Journal:  Immunology       Date:  1979-08       Impact factor: 7.397

3.  Antigenic relationship between the alpha-chain of C3, a leucocyte-surface antigen involved in the activation of phagocytic cells, and a 50,000 MW B-cell antigen.

Authors:  T F Schulz; H Scharfenberger; J D Lambris; P Rieber; G Riethmüller; M P Dierich
Journal:  Immunology       Date:  1985-04       Impact factor: 7.397

4.  Neoantigen of the polymerized ninth component of complement. Characterization of a monoclonal antibody and immunohistochemical localization in renal disease.

Authors:  R J Falk; A P Dalmasso; Y Kim; C H Tsai; J I Scheinman; H Gewurz; A F Michael
Journal:  J Clin Invest       Date:  1983-08       Impact factor: 14.808

5.  Cooperative interaction of factor B and other complement components with mononuclear cells in the antibody-independent lysis of xenogeneic erythrocytes.

Authors:  R E Hall; R M Blaese; A E Davis; J M Decker; B F Tack; H R Colten; A V Muchmore
Journal:  J Exp Med       Date:  1982-09-01       Impact factor: 14.307

Review 6.  Emerging Approaches for the Management of Chemotherapy-Induced Peripheral Neuropathy (CIPN): Therapeutic Potential of the C5a/C5aR Axis.

Authors:  Maria C Spera; Maria C Cesta; Mara Zippoli; Giustino Varrassi; Marcello Allegretti
Journal:  Pain Ther       Date:  2022-09-13

7.  Human monocyte spreading induced by factor Bb of the alternative pathway of complement activation. A possible role for C5 in monocyte spreading.

Authors:  J S Sundsmo; O Götze
Journal:  J Exp Med       Date:  1981-09-01       Impact factor: 14.307

8.  Chemotactic activity generated from the fifth component of complement by plasma kallikrein of the rabbit.

Authors:  R C Wiggins; P C Giclas; P M Henson
Journal:  J Exp Med       Date:  1981-06-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.